nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anthracycline induced left ventricular dysfunction in AML: A focus on the molecularly defined future of cardio-oncology
|
Chandra, Daniel J. |
|
|
133 |
C |
p. |
artikel |
2 |
A rare BCR-ABL1 transcript in chronic myeloid leukemia: Case report and literature review
|
Zhao, Zhen-Yu |
|
|
133 |
C |
p. |
artikel |
3 |
Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia
|
Owen, Carolyn |
|
|
133 |
C |
p. |
artikel |
4 |
Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy
|
Khadadah, Fatima M. |
|
|
133 |
C |
p. |
artikel |
5 |
Clonal hematopoiesis of indeterminate potential: Overmedicalization or context dependant relevance?
|
Patnaik, Mrinal M. |
|
|
133 |
C |
p. |
artikel |
6 |
Corrigendum to “Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities” [Leuk. Res. 130 (2023) 1–7]
|
Younes, Ismail Elbaz |
|
|
133 |
C |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
133 |
C |
p. |
artikel |
8 |
Growth and dormancy control of myeloma cells by mesenchymal stem cells
|
Mehdi, Syed J. |
|
|
133 |
C |
p. |
artikel |
9 |
Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study
|
De la Garza-Salazar, Fernando |
|
|
133 |
C |
p. |
artikel |
10 |
Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives
|
Ar, Muhlis Cem |
|
|
133 |
C |
p. |
artikel |
11 |
PI3K/AKT inhibitor BEZ-235 targets CCND2 and induces G1 arrest in breast implant-associated anaplastic large cell lymphoma
|
Nagel, Stefan |
|
|
133 |
C |
p. |
artikel |
12 |
Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies
|
Bhattacharjee, Urmimala |
|
|
133 |
C |
p. |
artikel |
13 |
Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML – A systematic review
|
Sherban, A. |
|
|
133 |
C |
p. |
artikel |
14 |
Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study
|
Kako, Shinichi |
|
|
133 |
C |
p. |
artikel |